1. "2010"
  2. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (83)
  2. Meeting Abstract (64)
Groups
  1. Human Oncology and Pathogenesis Program (147)
  2. GSK Faculty (144)
  3. Department of Medicine (107)
  4. Tow Center for Developmental Oncology (TCDO) (85)
  5. Solid Tumor Oncology Division (57)
  6. Center for Hematologic Malignancies (56)

More Groups

People
  1. Marc Ladanyi (43)
  2. David Solit (26)
  3. Ross Levine (23)
  4. Omar Abdel-Wahab (18)
  5. Adriana Heguy (16)
  6. Neal Rosen (14)

More People

Years
  1. 2010 (147)
Publications
  1. Modern Pathology (16)
  2. Journal of Clinical Oncology (14)
  3. Laboratory Investigation (13)
  4. Blood (12)
  5. Cancer Research (12)
  6. Cancer Cell (7)

More Publications

Publishers
  1. Nature Publishing Group (25)
  2. American Association for Cancer Research (18)
  3. Nature Research (16)
  4. American Society of Clinical Oncology (14)
  5. American Society of Hematology (12)
  6. Elsevier Inc. (8)

More Publishers

Results (147)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Over-expression of trail on donor T cells simultaneously ameliorates GVHD and enhances GVT
    Meeting Abstract

    Ghosh, A.; Holland, A. M.; Kappel, L. W.; Dogan, Y.; Yim, N.; Rao, U.; Smith, O. M.; Jenq, R. R.; Zakrzewski, J.; Na, I. K.; more...
    Biology of Blood and Marrow Transplantation (2010)

    Fulltext@MSK | Save
  • T-cell depleted allografts from unrelated donors confer a low risk of relapse on patients with hematologic malignancies
    Meeting Abstract

    Jakubowski, A. A.; Small, T.; Barker, J. N.; Boulad, F.; Castro-Malaspina, H. R.; Hsu, K. C.; Kernan, N.; Koehne, G.; Perales, M. A.; Prockop, S.; more...
    Biology of Blood and Marrow Transplantation (2010)

    Fulltext@MSK | Save
  • Temporary licensing of hyporesponsive NK cells following allogeneic HCT is not affected by T-cells in the stem cell allograft
    Meeting Abstract

    Tarek, N.; Yu, J.; Venstrom, J. M.; Hsu, K. C.
    Biology of Blood and Marrow Transplantation (2010)

    Fulltext@MSK | Save
  • The Memorial Sloan-Kettering experience with allogeneic stem cell transplantation for T cell non-Hodgkins lymphomas
    Meeting Abstract

    Goldberg, J. D.; Chou, J.; Jakubowski, A. A.; Arcila, M. E.; Teruya-Feldstein, J.; Horwitz, S.; Barker, J. N.; Boulad, F.; Castro-Malaspina, H. R.; Hsu, K.; more...
    Biology of Blood and Marrow Transplantation (2010)

    Fulltext@MSK | Save
  • Vandetanib (VAN) in locally advance or metastatic medullary thyroid cancer (MTC): A randomized, double-blind phase III trial (ZETA)
    Meeting Abstract

    Wells, S. A.; Robinson, B. G.; Gagel, R. F.; Dralle, H.; Fagin, J. A.; Santoro, M.; Baudin, E.; Vasselli, J. R.; Read, J.; Schlumberger, M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • EGFR mutations in men and cigarette smokers with lung adenocarcinoma
    Meeting Abstract

    Pietanza, M.; D'Angelo, S. P.; Johnson, M. L.; Paik, P. K.; Riely, G. J.; Miller, V. A.; Zakowski, M. F.; Rusch, V. W.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Clinical course of patients (pts) with acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKI)
    Meeting Abstract

    Oxnard, G. R.; Riely, G. J.; Arcila, M. H.; Kris, M. G.; Pao, W.; Ladanyi, M.; Miller, V. A.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase I safety and pharmacokinetic study of XL765 (SAR245409), a novel PI3K/TORC1/TORC2 inhibitor, in combination with temozolomide (TMZ) in patients (pts) with newly diagnosed malignant glioma
    Meeting Abstract

    Nghiemphu, P. L.; Omuro, A. M.; Cloughesy, T.; Mellinghoff, I. K.; Norden, A. G.; Nguyen, L. T.; Rajangam, K.; Wen, P. Y.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A gene expression signature associated with sensitivity to the multikinase inhibitor dasatinib: Implications for development of a noninvasive biomarker for personalized therapy based on circulating tumor cell analysis
    Meeting Abstract

    Mitsiades, N.; Antipin, Y.; Reva, B.; Schultz, N.; Danila, D. C.; Sung, C. C.; Anand, A.; Sander, C.; Scher, H. I.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Initial results of LC-MAP: An institutional program to routinely profile tumor specimens for the presence of mutations in targetable pathways in all patients with lung adenocarcinoma
    Meeting Abstract

    Kris, M. G.; Lau, C. Y.; Ang, D.; Brzostowski, E.; Riely, G. J.; Rusch, V. W.; Jhanwar, S.; Lash, A.; Zakowski, M. F.; Ladanyi, M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save